Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

kelly smith

- PMLiVE

LEO Pharma shares final long-term results for atopic dermatitis drug Adbry

The inflammatory skin condition affects over 26 million people in the US alone

- PMLiVE

MHRA approves CStone Pharmaceuticals’ sugemalimab to treat lung cancer in adults

Approximately 49,200 people are diagnosed with lung cancer every year in the UK

- PMLiVE

Countdown to an optimised drug launch: five determinants of success

The launch of a new pharmaceutical product depends on a host of determinants and it just takes one factor to send the launch awry

- PMLiVE

Novartis’ Scemblix granted FDA accelerated approval in newly diagnosed CML

Approximately 9,280 new cases of the disease are expected to be diagnosed in the US this year

- PMLiVE

Dermavant reports positive long-term results for Vtama cream in atopic dermatitis

More than 26 million people in the US are affected by the inflammatory skin condition

- PMLiVE

FlyPharma Vienna 2024: an event to remember

The 2024 Samedan FlyPharma Conference, held at Vienna AirportCity in Austria, took place from 23-24 October

- PMLiVE

The secrets of the pharmaceutical launch A-team

A new report reveals all

- PMLiVE

Is your influenza clinical trial prepared for the upcoming flu season? Part 3

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs...

Innovative Trials

- PMLiVE

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell,...

Innovative Trials

- PMLiVE

Is your influenza clinical trial prepared for the upcoming flu season? Part 1

The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere...

Innovative Trials

- PMLiVE

Recognizing C diff Awareness Month in 2024

Every year, the medical community recognizes the month of November as Clostridioides difficile (C. diff) Awareness month. C. diff is a public health threat that causes around 500,000 infections every...

Medscape Education

- PMLiVE

AbbVie to expand neuroscience pipeline with $1.4bn Aliada Therapeutics acquisition

The deal includes a candidate in phase 1 development for Alzheimer's disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links